In this issue: Two new drugs for treatment of hepatitis C; NSAIDs and myocardial infarction risk; AIM-HIGH clinical trial stopped; and FDA actions.
A large cohort study in Denmark showed that patients with a previous myocardial infarction (MI) who took any NSAID had an increased risk of death or a recurrent MI. The greater the use of an NSAID, the greater the risk.
Regular coffee consumption is associated with a prominent decrease in fatal or metastatic prostate cancer.
Unless there is another overt cause, such as occupational exposure to toxic inhalants, we generally expect chronic obstructive pulmonary disease (COPD) to be secondary to cigarette smoking.
The ECG shown above was interpreted as essentially "normal," showing nothing more than minimal nonspecific ST-T wave changes. Do you agree?
Dried plums (prunes) are safe and more effective than psyllium for treating mild-to-moderate constipation
The FDA has approved Boceprevir, a protease inhibitor for the treatment of chronic hepatitis C (HCV) infections.
Calcium supplements and MI; birth control pills and VTE; ACE inhibitors and breast cancer risk; spending on pharmaceuticals; and FDA actions.
Results of a new study indicate patients who have tested positive for herpes simplex virus type 2 (HSV-2) but don't have symptoms or genital lesions still experience virus shedding during subclinical episodes.
